 Developments receptor pharmacology migraine satisfactory animal model migraine attempts common mechanism action effective antimigraine agents benefit pathogenesis neurologic syndrome present review clinical data past years elucidation role specific receptor subtypes pathophysiology migraine large number acute prophylactic antimigraine agents share ability receptor subtypes human brain Table acute antimigraine drugs ergots sumatriptan share high affinity receptors affinity receptors receptors present certain intracranial blood vessels receptors nerve terminals release neurotransmitters receptor agonists release vasoactive pain-inducing substances perivascular space Conceivably drugs receptor progression perivascular process addition number prophylactic antimigraine drugs high affinity receptors human brain receptors certain blood vessels present nervous system receptors neuronal depolarizations cellular level receptor key role development inflammation certain smooth muscle systems ability antagonists perivascular inflammation efficacy prophylactic treatment migraine data novel approach analysis antimigraine agents Drugs use clinical migraine studies selectivity specific receptor subtype example agent high affinity selectivity receptors effectiveness lack thereof importance specific receptor site pathogenesis migraine Future attempts common mechanism action effective antimigraine agents elucidation pathogenesis neurologic syndrome